A comprehensive view of Laboratory Corp. of America Holdings (LabCorp). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Labcorp to announce fourth quarter and full year 2022 financial results on February 16, 2023
Published: January 25, 2023 by Laboratory Corp. of America Holdings (LabCorp)
Goldman Sachs identifies dozens of stocks that should withstand downturn; those best positioned to navigate hard landing include Home Depot, Costco, Kroger, Tyson Foods, Pfizer and Labcorp, while Tesla is well-poised to navigate mild recession
Published: January 17, 2023 by Forbes Inc.
Labcorp names Thomas Pike as president, CEO of its Drug Development Clinical Development Business Unit, to replace CEO Paul Kirchgraber, M.D. when Labcorp spins-off the business in mid-2023; Pike to serve as CEO, chairman of the board of the spin-off
Published: January 05, 2023 by Laboratory Corp. of America Holdings (LabCorp)
USPTO ISSUES TRADEMARK: LABCORP
Published: January 05, 2023 by U.S. Fed News
LabCorp gains on innovation amid currency headwinds, with company expecting full-year CAGR growth of nearly 8% since 2019, full-year revenue growth of 6% to 7%
Published: December 12, 2022 by Zack's Commentary

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count